<qa>  What is the name of the non-biologic DMARDS?- If using other non-biologic DMARDS, ex: methotrexate, sulfasalazine, hydroxychloroquine, azathioprine, cyclosporine, leflunomide, patient must demonstrate inadequate response, be on stable doses for at least 4 weeks prior to baseline visit. For methotrexate: patients must be on methotrexate for at least 3 months with 4 weeks stable dose, and will stay on stable dose during the study. 